Browse studies

Find your next paid study

70 recruiting studies matching your filters

Newest first Highest paying

Phase 2

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Atopic DermatitisAtopicDermatitis+5 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Apollo Therapeutics LtdNCT07599813

Sodium in the Skin and Atopic Dermatitis

The goal of this observational study is to understand factors associated with skin sodium storage in healthy adults and people with atopic dermatitis ages 50 a…

EczemaAtopic Dermatitis

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT06998446

Understanding Patient Engagement Trends in Atopic Dermatitis Clinical Research

Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundament…

Atopic Dermatitis

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Power Life Sciences Inc.NCT06174493

Phase 3

A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED PHASE 3 COMBINATION THERAPY STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF TILREKIMIG IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE OR OLDER WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

The purpose of this study is to find out how well tilrekimig works, how safe it is, and how it affects the body when used together with medicated creams or oin…

Atopic Dermatitis

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07765888

Remote eligible

Natural History and Genetics of Food Allergy and Related Conditions

Background: \- About 15 million Americans have a food allergy. Because there are no cures or effective prevention or treatment for food allergies, researchers…

Food AllergyLoeys-Dietz SyndromeAtopic Dermatitis+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT02504853

Phase 1

A Two-Part Phase 1, Randomized, Double-Blind, Placebo-Controlled First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN20423 in Adult Healthy Participants and Adult Participants With Atopic Dermatitis

This study will test a study medicine called REGN20423 to see how effective it is in healthy participants (in Part A) and participants with atopic dermatitis (…

Healthy VolunteerAtopic Dermatitis

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT07527923

Phase 1

A Randomized, Blinded, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 in HVs and Adult Patients With AD

This is a Phase 1, randomized, blinded, placebo controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study of BBT001 in healthy volunteers…

Atopic Dermatitis

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Bambusa TherapeuticsNCT06808477

Phase 4

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

The goal of this clinical trial is to demonstrate the feasibility of a trial that examines the impact of changes in dietary sodium intake on skin sodium levels…

Atopic Dermatitis (Eczema)Psoriasis

Estimated

~$25 – $900

Actual pay is set by the research site.

University of California, San FranciscoNCT07487831

A Prospective, Multi-center Observational Study Characterizing Clinical Outcomes of Patients Receiving Abrocitinib for Moderate-to-severe Atopic Dermatitis Who Had an Inadequate Response (or Intolerance) to ≤2 Previous Biologic Therapies Approved for Moderate-to-severe Atopic Dermatitis

This is a prospective, multi-center observational study characterizing clinical and patient reported outcomes of patients receiving abrocitinib for moderate-to…

Atopic DermatitisAtopic Dermatitis, UnspecifiedDermatitis, Atopic

Estimated

~$10 – $1,125

Actual pay is set by the research site.

PfizerNCT06899204

A US-Prospective, Registry-Based, Observational, Exposure Cohort Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

This observational (enrollment into the registry while the pregnancy is ongoing) study is being conducted to compare the frequency of major congenital malforma…

Pregnancy RelatedAtopic Dermatitis

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Incyte CorporationNCT06259669

Longitudinal "Real-World" Changes in Skin Microbial Ecology in Atopic Dermatitis (AD) and Psoriasis (PS) Patients

Everybody's skin has bacteria that normally lives on it. Previous research has shown that people with eczema (or atopic dermatitis \[AD\]) have much higher con…

Atopic DermatitisPsoriasisHealthy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of RochesterNCT04170244

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

This protocol is primarily looking to see if the IL-4Ra R576 polymorphism is associated with increased clinical, immunological and microbial markers of disease…

Atopic Dermatitis

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT04455906